Diffuse optical spectroscopic imaging correlates with final pathological response in breast cancer neoadjuvant chemotherapy. - Wikidata - awgldk - TriplyDB

Diffuse optical spectroscopic imaging correlates with final pathological response in breast cancer neoadjuvant chemotherapy.

Diffuse optical spectroscopic imaging correlates with final pathological response in breast cancer neoadjuvant chemotherapy.

http://www.wikidata.org/entity/Q34050338

about

Diffuse Optical Monitoring of the Neoadjuvant Breast Cancer Therapy.Multiparametric monitoring of chemotherapy treatment response in locally advanced breast cancer using quantitative ultrasound and diffuse optical spectroscopy Towards non-invasive characterization of breast cancer and cancer metabolism with diffuse optics.Adaptable near-infrared spectroscopy fiber array for improved coupling to different breast sizes during clinical MRI.Evolutionary game theory for physical and biological scientists. II. Population dynamics equations can be associated with interpretations.Optically measured microvascular blood flow contrast of malignant breast tumors.Tissue phantoms in multicenter clinical trials for diffuse optical technologies.Broadband optical mammography: chromophore concentration and hemoglobin saturation contrast in breast cancer Multiparametric magnetic resonance imaging for predicting pathological response after the first cycle of neoadjuvant chemotherapy in breast cancer.Differential diagnosis of breast masses in South Korean premenopausal women using diffuse optical spectroscopic imaging.Interplay between up-regulation of cytochrome-c-oxidase and hemoglobin oxygenation induced by near-infrared laser.Predicting Responses to Neoadjuvant Chemotherapy in Breast Cancer: ACRIN 6691 Trial of Diffuse Optical Spectroscopic Imaging Automatic and robust calibration of optical detector arrays for biomedical diffuse optical spectroscopy Mapping breast cancer blood flow index, composition, and metabolism in a human subject using combined diffuse optical spectroscopic imaging and diffuse correlation spectroscopy.Optical malignancy parameters for monitoring progression of breast cancer neoadjuvant chemotherapy Optical mammography: bilateral breast symmetry in hemoglobin saturation maps.Diffuse optical imaging using spatially and temporally modulated light.On the geometry dependence of differential pathlength factor for near-infrared spectroscopy. I. Steady-state with homogeneous medium.In vivo imaging of eribulin-induced reoxygenation in advanced breast cancer patients: a comparison to bevacizumab Chemotherapeutic drug-specific alteration of microvascular blood flow in murine breast cancer as measured by diffuse correlation spectroscopy.Hemodynamic signature of breast cancer under fractional mammographic compression using a dynamic diffuse optical tomography system.Anthropomorphic breast phantoms with physiological water, lipid, and hemoglobin content for near-infrared spectral tomography.Normalization of compression-induced hemodynamics in patients responding to neoadjuvant chemotherapy monitored by dynamic tomographic optical breast imaging (DTOBI).Hypoxia in melanoma: using optical spectroscopy and EF5 to assess tumor oxygenation before and during regional chemotherapy for melanoma.Vibrational spectroscopic imaging of living systems: An emerging platform for biology and medicine.Longitudinal optical monitoring of blood flow in breast tumors during neoadjuvant chemotherapy.Optical Mammography in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy: Individual Clinical Response Index.Predicting breast cancer response to neoadjuvant chemotherapy using pretreatment diffuse optical spectroscopic texture analysis.Effects of breast density and compression on normal breast tissue hemodynamics through breast tomosynthesis guided near-infrared spectral tomography.Intercoupling surface plasmon resonance and diffusion reflection measurements for real-time cancer detection.Value of combining dynamic contrast enhanced ultrasound and optoacoustic tomography for hypoxia imaging.Imaging Considerations and Interprofessional Opportunities in the Care of Breast Cancer Patients in the Neoadjuvant Setting.Emerging Breast Imaging Technologies on the Horizon.Dynamic Diffuse Optical Tomography for Monitoring Neoadjuvant Chemotherapy in Patients with Breast Cancer.Wearable near-infrared optical probe for continuous monitoring during breast cancer neoadjuvant chemotherapy infusions.The clinical evaluation of novel imaging methods for cancer management.Impact of errors in experimental parameters on reconstructed breast images using diffuse optical tomography.Tissue oxygen saturation predicts response to breast cancer neoadjuvant chemotherapy within 10 days of treatment

P2860

Q28710339-FC75832A-C152-4FF8-AB3E-BFBA4513ACA0 Q30375438-5095BAF6-B8B9-4EAC-AC9A-77796E8F8822 Q30435832-D8067FCD-8183-4B53-9B63-A6E1F2BEFC89 Q30736551-8CC782DA-4D28-4EDB-8A79-B03B4A01FFDF Q33808755-A7CEC9D1-A0A9-4E98-80BA-7A94EF044753 Q33812407-42D751AB-BD2A-443E-ADC1-4DD393053F37 Q34261949-0061D038-03E9-4B62-B981-B5E0B05002CA Q35187969-FA96E8A2-EA94-450D-BE23-1E7C9548ACD8 Q35754699-56126FA9-28F9-4426-8E16-5206C8D70EF6 Q36082374-EA881DA0-6A1D-4DB3-A0A2-459794447502 Q36092946-A1B856FE-4DC3-4914-814C-1D61613104ED Q36104503-FC5B9674-769A-457B-92F1-BAC787623929 Q36313614-E532DF86-AFAC-4816-8DB8-299FD76145BA Q36338809-1CB67BD9-9B57-4761-91C7-2C8D47C88625 Q36515249-A6C34CDE-2578-4CD5-BC47-9DADAE8D5928 Q36548558-6F16D335-72D2-4AB6-BD84-5A423B9EAAD5 Q36714281-170AB8EF-B4DE-4D2B-A7C4-D22F7F1AE0E2 Q36938479-32FC6620-E635-4272-A80B-417081645202 Q36964337-4B0ADB87-5411-4262-9B17-1AED473FA508 Q37270175-72F590C0-F323-4793-A736-BF07B0C325C3 Q37389915-059590BC-4C96-4F27-8B93-24596FE8179A Q37587245-D9E3B2C2-81EF-4631-95B0-0943A36633BF Q37671891-82307E89-0890-421A-8D66-21F00411848E Q37710877-DCC49051-5D06-40CF-82AF-C1B9214A7B92 Q38650243-39EC8051-47CC-417C-A223-1D4CC74FFD7B Q38731390-794339DD-BB33-4FA5-B22A-F403FF90B61F Q38770341-ED101EF0-E980-4D27-8718-3BE79E355EA7 Q38832422-EE795F05-15C0-44D9-B55A-CD38FAC5C827 Q39346419-E38B8BE6-EED3-4E22-8043-2F51257340E6 Q39372050-22B268E7-5FCB-4A01-95B9-AE586187201F Q41178403-235BC536-785C-434E-998B-2730E01C1C0E Q47959144-5C812E98-BC57-40E5-BFF4-D2FA2817D099 Q48508149-AC52E5E3-40B0-45FC-8467-6ABE0913699A Q50066888-F85C9F62-4A71-4B7B-AEBC-B7DF972C0F23 Q50324230-3460F6C0-F8C0-4322-A73C-1B02F639BA41 Q50896909-AFB84DC6-1CAB-4220-B295-B11A0269E447 Q55105014-34B7093C-3386-4BB5-B53E-C622DCFABD62 Q58594837-405B4E2E-B220-4A67-BD00-5B68AF8B6B22

P2860

Diffuse optical spectroscopic imaging correlates with final pathological response in breast cancer neoadjuvant chemotherapy.

http://www.wikidata.org/entity/Q34050338

description

2011 nî lūn-bûn

@nan

2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Diffuse optical spectroscopic ...... ncer neoadjuvant chemotherapy.

@ast

Diffuse optical spectroscopic ...... ncer neoadjuvant chemotherapy.

@en

Diffuse optical spectroscopic ...... ncer neoadjuvant chemotherapy.

@nl

type

label

Diffuse optical spectroscopic ...... ncer neoadjuvant chemotherapy.

@ast

Diffuse optical spectroscopic ...... ncer neoadjuvant chemotherapy.

@en

Diffuse optical spectroscopic ...... ncer neoadjuvant chemotherapy.

@nl

prefLabel

Diffuse optical spectroscopic ...... ncer neoadjuvant chemotherapy.

@ast

Diffuse optical spectroscopic ...... ncer neoadjuvant chemotherapy.

@en

Diffuse optical spectroscopic ...... ncer neoadjuvant chemotherapy.

@nl

P1433

Q34050338-F65FA7A6-E26F-4962-8E63-A9C90AA10415

P1476

Q34050338-B9097469-88BD-46FB-A95D-25341087655D

P2093

Q34050338-5080C486-2A06-49F1-89A8-B141D5C5DA4F

Q34050338-9CF91390-CCB2-42F1-9904-43FAAEEBDF05

Q34050338-D19B181E-AAE1-4FC4-8F5D-20B47E775E8F

Q34050338-D5B54F29-4A98-465E-BA84-B139D5B8A269

Q34050338-EDE99515-2747-4D6D-AC86-8C7E727225DD

P2860

Q34050338-0018E007-8BBF-4138-BEEF-7E8987EC32A4

Q34050338-06FE30A0-7438-4B8F-895F-BA5E8B02813C

Q34050338-0A74D30A-E447-46B0-8428-19E68E491EBE

Q34050338-0C99B7D2-D207-40EF-B9ED-50EA44F6FE9C

Q34050338-150CB276-6501-4A0C-BB4B-BC5F12E8AE55

Q34050338-243B9133-0440-4BB4-8F4C-1318D9008AAC

Q34050338-3FD6036B-6EFC-49A6-BC46-15555A15B63F

Q34050338-524E19B9-FF30-45E1-9FAE-7615EFCE152D

Q34050338-536BB156-170C-4EC8-9E0C-1BC307507E84

Q34050338-5ED63B44-F71D-4499-AA4C-859DCD2C60F2

P304

Q34050338-966494B6-79D4-41B2-9DD8-FF3724A2C206

P31

Q34050338-6BA71DD4-7182-4141-946C-60F048F334DB

P356

Q34050338-F257335A-CD66-4848-84B9-12CFB9467449

P407

Q34050338-D7F00F7A-A724-49B4-9437-EDB7883EF88F

P433

Q34050338-E4136525-7E79-44A1-9C45-67A63EB9D718

P478

Q34050338-8FB36218-3994-442A-952A-287D563A7915

P50

Q34050338-52C891B7-6A78-4003-AD2A-11F7956B07AE

P577

Q34050338-6B0EF292-CD97-4C76-8678-2C7D6DCA6815

P5875

Q34050338-6EE07FEC-174B-47D8-8CC2-817FC2C22F7A

P698

Q34050338-E277B4AA-FB46-4573-9A7D-61718EFB31C7

P921

Q34050338-9E133D7E-A6A7-4488-A985-592BD5CCE6F3

P932

Q34050338-1B12E0C4-64A3-42DB-9F54-119AC6999B9A

P356

P1433

Philosophical Transactions of the Royal Society A

P1476

Diffuse optical spectroscopic ...... ncer neoadjuvant chemotherapy.

@en

P2093

Albert E Cerussi

http://www.w3.org/2001/XMLSchema#string

David Hsiang

http://www.w3.org/2001/XMLSchema#string

John Butler

http://www.w3.org/2001/XMLSchema#string

Rita S Mehta

http://www.w3.org/2001/XMLSchema#string

Vaya W Tanamai

http://www.w3.org/2001/XMLSchema#string

P2860

Volume localized in vivo proton MR spectroscopy of breast carcinoma: variation of water-fat ratio in patients receiving chemotherapy.

Non-invasive in vivo characterization of breast tumors using photon migration spectroscopy

Comparison of water and lipid content measurements using diffuse optical spectroscopy and MRI in emulsion phantoms.

Combined diffuse optical spectroscopy and contrast-enhanced magnetic resonance imaging for monitoring breast cancer neoadjuvant chemotherapy: a case study.

Monitoring neoadjuvant chemotherapy in breast cancer using quantitative diffuse optical spectroscopy: a case study.

Diffuse optical tomography of breast cancer during neoadjuvant chemotherapy: a case study with comparison to MRI.

In vivo absorption, scattering, and physiologic properties of 58 malignant breast tumors determined by broadband diffuse optical spectroscopy.

Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy

Assessing the future of diffuse optical imaging technologies for breast cancer management

Diffuse optical spectroscopy measurements of healing in breast tissue after core biopsy: case study

P304

4512-4530

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1098/RSTA.2011.0279

http://www.w3.org/2001/XMLSchema#string

P407

P433

1955

http://www.w3.org/2001/XMLSchema#string

P478

369

http://www.w3.org/2001/XMLSchema#string

P50

Bruce J. Tromberg

P577

2011-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51721326

http://www.w3.org/2001/XMLSchema#string

P698

22006904

http://www.w3.org/2001/XMLSchema#string

P921

P932

3263790

http://www.w3.org/2001/XMLSchema#string